Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$44.8K
70.34K shares
What this filing means
DIBIASE MARY plans to sell 70.34K shares of X4 PHARMACEUTICALS, INC valued at approximately $44.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2024ACC: 0001973141-24-000493
Officer· Chief Operating Officer
Since Sep 2021
70.34K
Shares to sell
$44.8K
Approx. market value
67.69K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
PRSU
NA
10/4/2024
67.69KTotal acquired67.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/4/2024 | PRSU NA | 67.69K | — |
| Total | 67.69K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.64K
Market value
$1.7K
9/9/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
67.69K
Market value
$43.1K
10/7/2024
Total
Units
70.34K
Value
$44.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2024 | 2.64K | $1.7K | — | Completed |
| Planned — Approximate Date | ||||
10/7/2024 | 67.69K | $43.1K | NASDAQ | Planned |
| Total | 70.34K | $44.8K | ||